Skip to main content
Erschienen in: Medical & Biological Engineering & Computing 5/2019

16.01.2019 | Original Article

Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study

verfasst von: Monica Betta, Alberto Landi, Piero Manfredi, Marco Laurino

Erschienen in: Medical & Biological Engineering & Computing | Ausgabe 5/2019

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The introduction of mass vaccination against Varicella-Zoster-Virus (VZV) is being delayed in many European countries mainly because of the “fear” of a subsequent boom in natural herpes zoster (HZ) incidence in the first decades after the initiation of vaccination, caused by the expected decline in the protective effect of natural immunity boosting due to reduced virus circulation. Optimal control theory has proven to be a successful tool in understanding ways to curtail the spread of infectious diseases by devising the optimal disease intervention strategies. In this paper, we describe how a reduced ‘toy’ model can extract the essentials of the dynamics of the VZV transmission and reactivation in case of the study of optimal paths of varicella immunization programs. Results obtained using different optimization approaches are compared with the ones of a more realistic age-structured model. The reduced model shows some unreliable predictions in regards of model time scales about herpes zoster dynamic; nevertheless, it is able to reproduce the main qualitative dynamic of the more realistic model to the different optimization problems, while requiring a minimal number of parameters to be identified.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Anhänge
Nur mit Berechtigung zugänglich
Glossar
CMI
Cell-mediated immunity.
HZ
Herpes Zoster
VZV
Varicella-Zoster Virus
Literatur
1.
Zurück zum Zitat Heymann DL (2004) Control of communicable diseases, 18th edn. American Public Health Association, Washington Heymann DL (2004) Control of communicable diseases, 18th edn. American Public Health Association, Washington
2.
Zurück zum Zitat Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9–20PubMedPubMedCentral Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9–20PubMedPubMedCentral
3.
Zurück zum Zitat Oxman MN (2009) Herpes Zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc 109(6 Suppl 2):S13–7 Oxman MN (2009) Herpes Zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc 109(6 Suppl 2):S13–7
4.
Zurück zum Zitat Stefanoff P, Polkowska A, D’Ancona FP, Giambi C, Bruhl DL, O’Flanagna D, Dematte L, Lopalco P, and Johansen K (2010) Varicella and herpes zoster surveillance and vaccination reccommendations 2010-2011,” Vaccine Eropean New Integrated Collaboration Effort. VENICE II CONSORTIUM Stefanoff P, Polkowska A, D’Ancona FP, Giambi C, Bruhl DL, O’Flanagna D, Dematte L, Lopalco P, and Johansen K (2010) Varicella and herpes zoster surveillance and vaccination reccommendations 2010-2011,” Vaccine Eropean New Integrated Collaboration Effort. VENICE II CONSORTIUM
5.
Zurück zum Zitat Schuette M (1999) Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61(6):1031–1064CrossRefPubMed Schuette M (1999) Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61(6):1031–1064CrossRefPubMed
6.
Zurück zum Zitat Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125(3):651–669CrossRefPubMedPubMedCentral Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125(3):651–669CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ (2012) The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30(6):1225–1234CrossRefPubMed van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ (2012) The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30(6):1225–1234CrossRefPubMed
8.
Zurück zum Zitat Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20(19–20):2500–2507CrossRefPubMed Brisson M, Gay NJ, Edmunds WJ, Andrews NJ (2002) Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20(19–20):2500–2507CrossRefPubMed
9.
Zurück zum Zitat Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K (2010) Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect 138(4):469–481CrossRefPubMed Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K (2010) Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect 138(4):469–481CrossRefPubMed
10.
Zurück zum Zitat Hales CM, Harpaz R, Joesoef MR, Bialek SR (2013) Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 159(11):739CrossRefPubMedPubMedCentral Hales CM, Harpaz R, Joesoef MR, Bialek SR (2013) Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 159(11):739CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 29(13):2411–2420CrossRefPubMed van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N (2011) Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 29(13):2411–2420CrossRefPubMed
12.
Zurück zum Zitat Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P (2013) Hope-Simpson’s progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol 177(10):1134–1142CrossRefPubMed Guzzetta G, Poletti P, Del Fava E, Ajelli M, Scalia Tomba GP, Merler S, Manfredi P (2013) Hope-Simpson’s progressive immunity hypothesis as a possible explanation for herpes zoster incidence data. Am J Epidemiol 177(10):1134–1142CrossRefPubMed
13.
Zurück zum Zitat Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, Manfredi P (2013) Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One 8(4):e60732CrossRefPubMedPubMedCentral Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, Manfredi P (2013) Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One 8(4):e60732CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P (2018) Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Vaccine 36(8):1116–1125CrossRefPubMed Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P (2018) Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Vaccine 36(8):1116–1125CrossRefPubMed
15.
Zurück zum Zitat Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, Merler S (2018) The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study. BMC Med 16(1):117CrossRefPubMedPubMedCentral Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, Merler S (2018) The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study. BMC Med 16(1):117CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Betta M, Laurino M, Pugliese A, Guzzetta G, Landi A, Manfredi P (1826) Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proc Biol Sci 283:2016 Betta M, Laurino M, Pugliese A, Guzzetta G, Landi A, Manfredi P (1826) Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proc Biol Sci 283:2016
17.
Zurück zum Zitat Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28(11):954–959CrossRefPubMed Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF (2009) The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 28(11):954–959CrossRefPubMed
18.
Zurück zum Zitat Lenhart S and Workman JT (2007) Optimal control applied to biological models Lenhart S and Workman JT (2007) Optimal control applied to biological models
19.
Zurück zum Zitat Sharomi O, Malik T (2017) Optimal control in epidemiology. Ann Oper Res 251(1–2):55–71CrossRef Sharomi O, Malik T (2017) Optimal control in epidemiology. Ann Oper Res 251(1–2):55–71CrossRef
21.
Zurück zum Zitat Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP (2014) Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. Lancet Infect Dis 14(12):1189–1195CrossRefPubMedPubMedCentral Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP (2014) Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. Lancet Infect Dis 14(12):1189–1195CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ (2009) Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 27(9):1454–1467CrossRefPubMed van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ (2009) Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 27(9):1454–1467CrossRefPubMed
23.
Zurück zum Zitat Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MVM, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E (2007) The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25(45):7866–7872CrossRefPubMed Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MVM, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E (2007) The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 25(45):7866–7872CrossRefPubMed
24.
Zurück zum Zitat Goeyvaerts N, Hens N, Ogunjimi B, Aerts M, Shkedy Z, Van Damme P, Beutels P (2010) Estimating infectious disease parameters from data on social contacts and serological status. J R Stat Soc Ser C (Appl Stat) 59(2):255–277CrossRef Goeyvaerts N, Hens N, Ogunjimi B, Aerts M, Shkedy Z, Van Damme P, Beutels P (2010) Estimating infectious disease parameters from data on social contacts and serological status. J R Stat Soc Ser C (Appl Stat) 59(2):255–277CrossRef
26.
Zurück zum Zitat Bilcke J, Ogunjimi B, Marais C, de Smet F, Callens M, Callaert K, van Kerschaver E, Ramet J, van Damme P, Beutels P (2012) The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 140(11):2096–2109CrossRefPubMed Bilcke J, Ogunjimi B, Marais C, de Smet F, Callens M, Callaert K, van Kerschaver E, Ramet J, van Damme P, Beutels P (2012) The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 140(11):2096–2109CrossRefPubMed
27.
Zurück zum Zitat Pontryagin LS (1987) Mathematical theory of optimal processes Pontryagin LS (1987) Mathematical theory of optimal processes
28.
Zurück zum Zitat The Mathworks Inc, “Matlab.” 2009 The Mathworks Inc, “Matlab.” 2009
Metadaten
Titel
Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study
verfasst von
Monica Betta
Alberto Landi
Piero Manfredi
Marco Laurino
Publikationsdatum
16.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Medical & Biological Engineering & Computing / Ausgabe 5/2019
Print ISSN: 0140-0118
Elektronische ISSN: 1741-0444
DOI
https://doi.org/10.1007/s11517-018-1938-5

Weitere Artikel der Ausgabe 5/2019

Medical & Biological Engineering & Computing 5/2019 Zur Ausgabe